These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cutting edge issues in autoimmune hepatitis. Liberal R; Krawitt EL; Vierling JM; Manns MP; Mieli-Vergani G; Vergani D J Autoimmun; 2016 Dec; 75():6-19. PubMed ID: 27502148 [TBL] [Abstract][Full Text] [Related]
24. Chinese medicine in the treatment of autoimmune hepatitis: Progress and future opportunities. Liu J; Ma Z; Li H; Li X Animal Model Exp Med; 2022 Apr; 5(2):95-107. PubMed ID: 35263512 [TBL] [Abstract][Full Text] [Related]
25. Autoimmune hepatitis in children: what is different from adult AIH? Mieli-Vergani G; Vergani D Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002 [TBL] [Abstract][Full Text] [Related]
26. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000 [TBL] [Abstract][Full Text] [Related]
27. Autoimmune hepatitis: a comprehensive review. Liberal R; Grant CR; Mieli-Vergani G; Vergani D J Autoimmun; 2013 Mar; 41():126-39. PubMed ID: 23218932 [TBL] [Abstract][Full Text] [Related]
32. Autoimmune hepatitis in children: an overview of the disease focusing on current therapies. Della Corte C; Sartorelli MR; Sindoni CD; Girolami E; Giovannelli L; Comparcola D; Nobili V Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):739-46. PubMed ID: 22495399 [TBL] [Abstract][Full Text] [Related]
33. Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes. Strzepka J; Schwartz BA; Ritz EM; Aloman C; Reau N J Clin Gastroenterol; 2024 Jan; 58(1):91-97. PubMed ID: 36729430 [TBL] [Abstract][Full Text] [Related]
34. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model. Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259 [TBL] [Abstract][Full Text] [Related]
35. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095 [TBL] [Abstract][Full Text] [Related]
36. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis. Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311 [TBL] [Abstract][Full Text] [Related]